Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BioNTech Doses First Patient in Mid-Stage Study of mRNA Cancer Vaccine

06/18/2021 | 05:50am EDT


© MT Newswires 2021
All news about BIONTECH SE
06:06aPFIZER : Should I Get the Covid-19 Vaccine While Pregnant or Breastfeeding? Expe..
AQ
08/01MARKET CHATTER : Pfizer, Moderna Raise COVID-19 Vaccine Prices in EU Supply Cont..
MT
07/31MODERNA : U.S. CDC Says Delivered 400,675,525 Doses Of COVID-19 Vaccine As Of Ju..
RE
07/30MODERNA : Most COVID-19 cases in Massachusetts outbreak among vaccinated, says C..
RE
07/30Misleading With Numbers
AQ
07/29PFIZER : Israel to give Pfizer COVID-19 booster to 60 and over as Delta spreads
AQ
07/29PFIZER : Israel to offer 3rd COVID booster shot to older citizens
AQ
07/29EUROPEAN MIDDAY BRIEFING : Stocks Rise as -2-
DJ
07/29EMEA MORNING BRIEFING : Stocks to Open Lower After -2-
DJ
07/28MODERNA : Pfizer says 2021 COVID-19 vaccine sales to top $33.5 billion, sees nee..
RE
More news
Financials
Sales 2021 12 451 M 14 804 M 14 804 M
Net income 2021 7 102 M 8 444 M 8 444 M
Net cash 2021 7 718 M 9 177 M 9 177 M
P/E ratio 2021 9,73x
Yield 2021 -
Capitalization 66 819 M 79 303 M 79 445 M
EV / Sales 2021 4,75x
EV / Sales 2022 4,99x
Nbr of Employees 2 200
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 276,66 €
Average target price 155,21 €
Spread / Average Target -43,9%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE302.78%79 303
GILEAD SCIENCES, INC.17.22%85 648
WUXI APPTEC CO., LTD.33.61%59 516
REGENERON PHARMACEUTICALS18.94%59 505
VERTEX PHARMACEUTICALS-14.71%52 296
GENMAB A/S15.10%29 546